/Companies

Dopavision

5 known investors

Find your way into Dopavision

Sign up to see every warm intro you have to Dopavision

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Dopavision team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Dopavision develops digital therapeutics that use selective ocular light stimulation delivered through consumer electronics to non-invasively activate the eye's signaling pathways. Its lead product targets slowing the progression of myopia in children and adolescents.

Investors · 5

Also in the syndicate · 3

Ababax HealthFlying HealthNovartis Pharmaceuticals

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Dopavision do?
Dopavision develops digital therapeutics that use selective ocular light stimulation delivered through consumer electronics to non-invasively activate the eye's signaling pathways. Its lead product targets slowing the progression of myopia in children and adolescents.
Who are Dopavision's investors?
Dopavision's investors include Seventure Partners, Boehringer Ingelheim Venture Fund.